chr19-4013264-C-T
Position:
Variant summary
Our verdict is Benign. Variant got -17 ACMG points: 0P and 17B. BP4_StrongBP6_Very_StrongBP7BS2
The NM_015897.4(PIAS4):c.369C>T(p.Pro123Pro) variant causes a synonymous change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00825 in 1,613,310 control chromosomes in the GnomAD database, including 73 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Likely benign (★★).
Frequency
Genomes: 𝑓 0.0063 ( 4 hom., cov: 32)
Exomes 𝑓: 0.0085 ( 69 hom. )
Consequence
PIAS4
NM_015897.4 synonymous
NM_015897.4 synonymous
Scores
2
Clinical Significance
Conservation
PhyloP100: -0.180
Genes affected
PIAS4 (HGNC:17002): (protein inhibitor of activated STAT 4) Enables SUMO ligase activity and ubiquitin protein ligase binding activity. Involved in negative regulation of transcription, DNA-templated; positive regulation of protein sumoylation; and protein sumoylation. Located in cytoplasm and nucleus. [provided by Alliance of Genome Resources, Apr 2022]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Benign. Variant got -17 ACMG points.
BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.49).
BP6
Variant 19-4013264-C-T is Benign according to our data. Variant chr19-4013264-C-T is described in ClinVar as [Likely_benign]. Clinvar id is 771210.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BP7
Synonymous conserved (PhyloP=-0.18 with no splicing effect.
BS2
High AC in GnomAd4 at 959 AD gene.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
PIAS4 | NM_015897.4 | c.369C>T | p.Pro123Pro | synonymous_variant | 2/11 | ENST00000262971.3 | NP_056981.2 | |
PIAS4 | XM_011528060.3 | c.426C>T | p.Pro142Pro | synonymous_variant | 2/11 | XP_011526362.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
PIAS4 | ENST00000262971.3 | c.369C>T | p.Pro123Pro | synonymous_variant | 2/11 | 1 | NM_015897.4 | ENSP00000262971.1 | ||
PIAS4 | ENST00000593518.1 | n.372C>T | non_coding_transcript_exon_variant | 2/3 | 4 | |||||
PIAS4 | ENST00000599999.5 | n.376C>T | non_coding_transcript_exon_variant | 2/4 | 3 | |||||
PIAS4 | ENST00000600566.5 | n.374C>T | non_coding_transcript_exon_variant | 2/4 | 2 |
Frequencies
GnomAD3 genomes AF: 0.00630 AC: 959AN: 152166Hom.: 4 Cov.: 32
GnomAD3 genomes
AF:
AC:
959
AN:
152166
Hom.:
Cov.:
32
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD3 exomes AF: 0.00604 AC: 1516AN: 250958Hom.: 13 AF XY: 0.00607 AC XY: 825AN XY: 135852
GnomAD3 exomes
AF:
AC:
1516
AN:
250958
Hom.:
AF XY:
AC XY:
825
AN XY:
135852
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad SAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.00845 AC: 12347AN: 1461026Hom.: 69 Cov.: 32 AF XY: 0.00823 AC XY: 5981AN XY: 726824
GnomAD4 exome
AF:
AC:
12347
AN:
1461026
Hom.:
Cov.:
32
AF XY:
AC XY:
5981
AN XY:
726824
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome AF: 0.00630 AC: 959AN: 152284Hom.: 4 Cov.: 32 AF XY: 0.00686 AC XY: 511AN XY: 74468
GnomAD4 genome
AF:
AC:
959
AN:
152284
Hom.:
Cov.:
32
AF XY:
AC XY:
511
AN XY:
74468
Gnomad4 AFR
AF:
Gnomad4 AMR
AF:
Gnomad4 ASJ
AF:
Gnomad4 EAS
AF:
Gnomad4 SAS
AF:
Gnomad4 FIN
AF:
Gnomad4 NFE
AF:
Gnomad4 OTH
AF:
Alfa
AF:
Hom.:
Bravo
AF:
Asia WGS
AF:
AC:
3
AN:
3478
EpiCase
AF:
EpiControl
AF:
ClinVar
Significance: Benign/Likely benign
Submissions summary: Benign:3
Revision: criteria provided, multiple submitters, no conflicts
LINK: link
Submissions by phenotype
not provided Benign:3
Benign, criteria provided, single submitter | not provided | Breakthrough Genomics, Breakthrough Genomics | - | - - |
Benign, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Jun 27, 2018 | - - |
Likely benign, criteria provided, single submitter | clinical testing | CeGaT Center for Human Genetics Tuebingen | Apr 01, 2022 | PIAS4: BP4, BP7 - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
CADD
Benign
DANN
Benign
RBP_binding_hub_radar
RBP_regulation_power_radar
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at